Campbell & Co. Investment Adviser »

Springworks Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $432k 14k 32.04
2024-03-31 $819k 17k 49.22

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Springworks Therapeutics

Vanguard Group
BlackRock
BlackRock
Deep Track Capital
T. Rowe Price Associates
Boxer Capital
State Street Corporation
Maverick Capital
Marshall Wace
Pictet Asset Management Holding SA
Geode Capital Management
Arrowpoint Asset Management
OrbiMed Advisors
Woodline Partners
Siren

View all funds holding Springworks Therapeutics